Cargando…

Telemedicine in Overactive Bladder Syndrome

PURPOSE OF REVIEW: This review discusses the role and benefits of telemedicine as an integral component of the post-pandemic care paradigm in urological practice and, in particular, as part of the care of patients with overactive bladder (OAB). RECENT FINDINGS: The COVID-19 pandemic accelerated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jericevic, Dora, Brucker, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015147/
https://www.ncbi.nlm.nih.gov/pubmed/37193335
http://dx.doi.org/10.1007/s11884-023-00689-4
_version_ 1784907154696699904
author Jericevic, Dora
Brucker, Benjamin
author_facet Jericevic, Dora
Brucker, Benjamin
author_sort Jericevic, Dora
collection PubMed
description PURPOSE OF REVIEW: This review discusses the role and benefits of telemedicine as an integral component of the post-pandemic care paradigm in urological practice and, in particular, as part of the care of patients with overactive bladder (OAB). RECENT FINDINGS: The COVID-19 pandemic accelerated the implementation of telemedicine across almost every medical specialty and (at least temporarily) swept away barriers including those regarding reimbursement and licensure. Telemedicine benefits patients and providers alike including savings on transportation costs, access to specialists or tertiary care from geographically remote locations, and minimized exposure to a contagious illness. Integration of telemedicine into clinical practice can reduce costs for office/exam space and staffing overhead, as well as facilitate greater scheduling efficiency. Many, if not most, aspects of care for the uncomplicated OAB patient can be as effectively managed remotely as with in-person encounters, across the treatment algorithm. SUMMARY: Telemedicine will almost certainly remain a key component in the care of OAB, general urology, and throughout all medical specialties.
format Online
Article
Text
id pubmed-10015147
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-100151472023-03-15 Telemedicine in Overactive Bladder Syndrome Jericevic, Dora Brucker, Benjamin Curr Bladder Dysfunct Rep Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors) PURPOSE OF REVIEW: This review discusses the role and benefits of telemedicine as an integral component of the post-pandemic care paradigm in urological practice and, in particular, as part of the care of patients with overactive bladder (OAB). RECENT FINDINGS: The COVID-19 pandemic accelerated the implementation of telemedicine across almost every medical specialty and (at least temporarily) swept away barriers including those regarding reimbursement and licensure. Telemedicine benefits patients and providers alike including savings on transportation costs, access to specialists or tertiary care from geographically remote locations, and minimized exposure to a contagious illness. Integration of telemedicine into clinical practice can reduce costs for office/exam space and staffing overhead, as well as facilitate greater scheduling efficiency. Many, if not most, aspects of care for the uncomplicated OAB patient can be as effectively managed remotely as with in-person encounters, across the treatment algorithm. SUMMARY: Telemedicine will almost certainly remain a key component in the care of OAB, general urology, and throughout all medical specialties. Springer US 2023-03-15 2023 /pmc/articles/PMC10015147/ /pubmed/37193335 http://dx.doi.org/10.1007/s11884-023-00689-4 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors)
Jericevic, Dora
Brucker, Benjamin
Telemedicine in Overactive Bladder Syndrome
title Telemedicine in Overactive Bladder Syndrome
title_full Telemedicine in Overactive Bladder Syndrome
title_fullStr Telemedicine in Overactive Bladder Syndrome
title_full_unstemmed Telemedicine in Overactive Bladder Syndrome
title_short Telemedicine in Overactive Bladder Syndrome
title_sort telemedicine in overactive bladder syndrome
topic Voiding Dysfunction Evaluation (B Brucker and B Peyronnet, Section Editors)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015147/
https://www.ncbi.nlm.nih.gov/pubmed/37193335
http://dx.doi.org/10.1007/s11884-023-00689-4
work_keys_str_mv AT jericevicdora telemedicineinoveractivebladdersyndrome
AT bruckerbenjamin telemedicineinoveractivebladdersyndrome